This is supported by our in vitro observations and early in vivo results by which the reduction of ADAM15 expression or inhibition of its catalytic activity, reduces cellular motility and invasiveness and inhibits tumor growth in animal models. The gene discussed is ADAM15; the disease is neoplasm.